// App-Quantinova.ai

: CD22 CAR T-CELL THERAPY IN 34 REFRACTORY OR RELAPSED B ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS

Researchers

Presenter

  • Jing Pan

Principal Investigators

  • BIPING DENG

  • Shuangyou Liu

  • Tong Wu

  • Zhiyong Gao

  • Yuehui Lin

  • Yongqiang Zhao

  • Yan Zhang

  • Xiyou Tan

  • Alex H. Chang

  • Chunrong Tong

Medical Centers

  • Department of Hematology,Fuxing Hospital,Beijing,China

  • Department of Immunotherapy,Beijing Boren Hospital,Beijing,China

  • Department of Bone Marrow Transplantation, Beijing Boren Hospital, Beijing, China

  • Beijing Hospital, Beijing, China

  • Clinical Translational Research Center,Tongji University School of Medicine,Shanghai,China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • B-cell acute lymphoblastic leukemia

Biomarkers

  • Peripheral blood mononuclear cell

  • Twist-related protein 1

Drug/Treatment

  • Allopurinol

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved